OFIX — Orthofix Medical Income Statement
0.000.00%
Last trade - 00:00
- $485.91m
- $566.40m
- $746.64m
- 32
- 73
- 55
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 460 | 407 | 464 | 461 | 747 |
Cost of Revenue | |||||
Gross Profit | 359 | 305 | 350 | 337 | 486 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 479 | 413 | 473 | 474 | 886 |
Operating Profit | -18.8 | -6.27 | -8.31 | -13.3 | -139 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -27 | -0.368 | -13.5 | -17.7 | -149 |
Provision for Income Taxes | |||||
Net Income After Taxes | -28.5 | 2.52 | -38.4 | -19.7 | -151 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -28.5 | 2.52 | -38.4 | -19.7 | -151 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -28.5 | 2.52 | -38.4 | -19.7 | -151 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.329 | 0.13 | -1.48 | -0.905 | -3.03 |